BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26308055)

  • 21. Heme Oxygenase-1 Induction by Cobalt Protoporphyrin Ameliorates Cholestatic Liver Disease in a Xenobiotic-Induced Murine Model.
    Kim JY; Choi Y; Leem J; Song JE
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.
    Wang H; Zhang J; Zhang X; Zhao N; Zhou Z; Tao L; Fu L; Peng S; Chai J
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166556. PubMed ID: 36154893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
    Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
    Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal obesogenic diet enhances cholestatic liver disease in offspring.
    Thompson MD; Hinrichs H; Faerber A; Tarr PI; Davidson NO
    J Lipid Res; 2022 May; 63(5):100205. PubMed ID: 35341737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
    Joshi N; Kopec AK; Cline-Fedewa H; Luyendyk JP
    Toxicology; 2017 Feb; 377():73-80. PubMed ID: 28049044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pipe-3D: A Pipeline Based on Immunofluorescence, 3D Confocal Imaging, Reconstructions, and Morphometry for Biliary Network Analysis in Cholestasis.
    Damle-Vartak A; Begher-Tibbe B; Gunther G; Geisler F; Vartak N; Hengstler JG
    Methods Mol Biol; 2019; 1981():25-53. PubMed ID: 31016646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice.
    Zhang Z; Zhong X; Shen H; Sheng L; Liangpunsakul S; Lok AS; Omary MB; Wang S; Rui L
    Nat Commun; 2022 Aug; 13(1):5111. PubMed ID: 36042192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Wnt Secretion by Macrophages Promotes Hepatobiliary Injury after Administration of 3,5-Diethoxycarbonyl-1, 4-Dihydrocollidine Diet.
    Jiang A; Okabe H; Popovic B; Preziosi ME; Pradhan-Sundd T; Poddar M; Singh S; Bell A; England SG; Nagarajan S; Monga SP
    Am J Pathol; 2019 Mar; 189(3):590-603. PubMed ID: 30610845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis.
    Furuya S; Argemi J; Uehara T; Katou Y; Fouts DE; Schnabl B; Dubuquoy L; Belorkar A; Vadigepalli R; Kono H; Bataller R; Rusyn I
    Alcohol Clin Exp Res; 2020 Jan; 44(1):87-101. PubMed ID: 31710124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic niches.
    Chen L; Luo M; Sun X; Qin J; Yu C; Wen Y; Zhang Q; Gu J; Xia Q; Kong X
    Cell Death Dis; 2016 Jun; 7(6):e2257. PubMed ID: 27277679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apamin suppresses biliary fibrosis and activation of hepatic stellate cells.
    Kim JY; An HJ; Kim WH; Park YY; Park KD; Park KK
    Int J Mol Med; 2017 May; 39(5):1188-1194. PubMed ID: 28405682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
    Ikenaga N; Peng ZW; Vaid KA; Liu SB; Yoshida S; Sverdlov DY; Mikels-Vigdal A; Smith V; Schuppan D; Popov YV
    Gut; 2017 Sep; 66(9):1697-1708. PubMed ID: 28073888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease.
    Preisegger KH; Factor VM; Fuchsbichler A; Stumptner C; Denk H; Thorgeirsson SS
    Lab Invest; 1999 Feb; 79(2):103-9. PubMed ID: 10068199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.
    Lee SJ; Kim KH; Pak SC; Kang YN; Yoon GS; Park KK
    Int J Clin Exp Pathol; 2015; 8(10):12688-97. PubMed ID: 26722458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis.
    Miyao M; Ozeki M; Abiru H; Manabe S; Kotani H; Tsuruyama T; Tamaki K
    Dig Liver Dis; 2013 Mar; 45(3):216-25. PubMed ID: 23107486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease.
    Hao J; Shen X; Lu K; Xu Y; Chen Y; Liu J; Shao X; Zhu C; Ding Y; Xie X; Wu J; Yang Q
    J Tradit Complement Med; 2023 Jul; 13(4):345-357. PubMed ID: 37396159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-series metabolomics insights into the progressive characteristics of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver fibrosis in mice.
    Li Y; Xue H; Fang S; Wang G; Wang Y; Wang T; Shi R; Wu J; Ma Y
    J Pharm Biomed Anal; 2021 May; 198():113986. PubMed ID: 33690095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of melittin on inflammation and apoptosis in acute liver failure.
    Park JH; Kim KH; Lee WR; Han SM; Park KK
    Apoptosis; 2012 Jan; 17(1):61-9. PubMed ID: 21928088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Inhibition of the TGF-β1/Smad Pathway by
    Shen Y; Jiang B; Zhang C; Wu Q; Li L; Jiang P
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury.
    Addante A; Roncero C; Almalé L; Lazcanoiturburu N; García-Álvaro M; Fernández M; Sanz J; Hammad S; Nwosu ZC; Lee SJ; Fabregat I; Dooley S; Ten Dijke P; Herrera B; Sánchez A
    Liver Int; 2018 Sep; 38(9):1664-1675. PubMed ID: 29751359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.